Medicine and Dentistry
Antiretroviral Therapy
100%
Proteinase Inhibitor
100%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Human Immunodeficiency Virus
66%
Clinical Trial
33%
Clinical Research
33%
Proportional Hazards Model
33%
Retroviridae
33%
Diseases
33%
Keyphrases
Virological Failure
100%
Combined Antiretroviral Therapy (cART)
100%
Protease Inhibitors
30%
Antiretroviral Resistance
30%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
30%
Antiviral Drugs
20%
Three-class
20%
Community-based Programs
10%
Clinical Research
10%
Randomized Trial
10%
Human Immunodeficiency Virus Type 1 (HIV-1)
10%
Antiretroviral Therapy
10%
Treatment-naïve
10%
Infected Individual
10%
Retrovirus
10%
HIV RNA
10%
Clinical Trial Data
10%
Suppressive Therapy
10%
Specific Factors
10%
Prospective Clinical Trial
10%
Disease-specific
10%
Non-associated
10%
Multivariate Cox Regression Analysis
10%
Medication Resistance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Proteinase Inhibitor
100%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
HIV
66%
Clinical Trial
33%
Clinical Research
33%
Retrovirus
33%
Diseases
33%